A randomized, double-blind study of antipsychotic drugs combined with MCT in the treatment of refractory schizophrenia

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 25cbb05077f0d88b7ed4498d7cc71c9d29d70018
First added on: Apr 08, 2025